HaploX Biotechnology

About:

HaploX Biotechnology is a Shenzhen-based genetic sequencing company.

Website: https://www.haplox.com/

Top Investors: Shenzhen Capital Group, SBCVC, Youchoose Capital, CNCB Capital, Kexin Capital

Description:

HaploX is a biotechnology company that aims to improve cancer patient management by integrating liquid biopsy technology, gene sequencing, artificial intelligence, big data, and other technologies. Its technologies include tools for extracting and amplifying ultra-low concentrations of DNA from liquid samples, performing tagged sequencing, and managing and analyzing the resulting data.

Total Funding Amount:

$72.2M

Headquarters Location:

Shenzhen, Guangdong, China

Founded Date:

2014-01-01

Founders:

Mingyan Xu

Number of Employees:

501-1000

Last Funding Date:

2022-07-26

IPO Status:

Private

Industries:

© 2025 bioDAO.ai